Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Friedberg

Showing results (21-30 of 300) with videos related to

Pageof 30
Sort By:
Haematologica|March 4, 2008
Secondary malignancies after therapy of indolent non-Hodgkin's lymphomaJonathan W Friedberg
Blood|January 15, 2011
CLL microenvironment: macro importantJonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
End of rituximab maintenance for low-tumor burden follicular lymphomaJonathan W Friedberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Developing new monoclonal antibodies for aggressive lymphoma: a challenging road in the rituximab eraJonathan W Friedberg
Blood|January 30, 2010
PET positive, PET negative, or PET peeve?Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Progress in Advanced-Stage Follicular LymphomaJonathan W Friedberg
Leukemia & Lymphoma|April 7, 2009
The emerging role of bendamustine in follicular lymphomaJonathan W Friedberg
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
Optimizing the Use of Oral Therapy in LymphomaJonathan W Friedberg
Chinese Clinical Oncology|April 6, 2015
Double hit diffuse large B-cell lymphomas: diagnostic and therapeutic challengesJonathan W Friedberg
Leukemia & Lymphoma|February 24, 2009
Seeking wisdom from the SeerPeter McLaughlin, Jonathan W Friedberg
Pageof 30

Showing results (21-30 of 300) with videos related to

Sort By:
Pageof 30
Haematologica|March 4, 2008
Secondary malignancies after therapy of indolent non-Hodgkin's lymphomaJonathan W Friedberg
Blood|January 15, 2011
CLL microenvironment: macro importantJonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
End of rituximab maintenance for low-tumor burden follicular lymphomaJonathan W Friedberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Developing new monoclonal antibodies for aggressive lymphoma: a challenging road in the rituximab eraJonathan W Friedberg
Blood|January 30, 2010
PET positive, PET negative, or PET peeve?Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Progress in Advanced-Stage Follicular LymphomaJonathan W Friedberg
Leukemia & Lymphoma|April 7, 2009
The emerging role of bendamustine in follicular lymphomaJonathan W Friedberg
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
Optimizing the Use of Oral Therapy in LymphomaJonathan W Friedberg
Chinese Clinical Oncology|April 6, 2015
Double hit diffuse large B-cell lymphomas: diagnostic and therapeutic challengesJonathan W Friedberg
Leukemia & Lymphoma|February 24, 2009
Seeking wisdom from the SeerPeter McLaughlin, Jonathan W Friedberg
Pageof 30